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ABSTRACT 
MOBILE BLOOD DONATION LOGISTICS: 
CASE FOR TURKISH RED CRESCENT 
 
Feyza Güliz Şahinyazan 
M.S. in Industrial Engineering 
Advisors: Assoc. Prof. Bahar Yetiş Kara 
Assoc. Prof. Mehmet Rüştü Taner 
July, 2012 
 
Blood transfusion is one of the most critical operations in various medical interventions. 
Currently, the only authorized way of securing the required blood for transfusion is 
through voluntary donations. For this reason, reorganizing blood donation operations to 
create an operable and efficient system is of utmost importance. In this study, a mobile 
blood collection system is designed for Turkish Red Crescent (TRC) to increase blood 
collection levels. This design also takes into account operational costs as a second 
objective so as to aim the collection of large amounts of blood at reasonable cost. In the 
current system, TRC has bloodmobiles that perform independent direct tours to certain 
activities (fairs, college fests etc.), but at the end of each day, they bring the collected 
blood to a designated depot to prevent its spoilage. Considering blood’s considerably 
short shelf-life of 24 hrs, these direct tours may seem justifiable yet they are not efficient 
in terms of logistics costs. The proposed system consists of classic bloodmobiles and a 
new vehicle – called the shuttle – which visits the bloodmobiles in the field and transfers 
the collected blood to the blood centers, so that bloodmobiles can continue their tours 
without having to make daily returns to the depot.  
A mathematical model is developed to determine the stops of bloodmobiles, the duration 
of each visit as well as the tours of the bloodmobiles and the shuttle. In the literature, a 
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study that covers all these decisions does not exist. Therefore, a new extension of 
Selective Vehicle Routing Problem (SVRP) is defined, called SVRP with Integrated 
Tours. Also, a 2-stage IP based heuristic algorithm is developed for the same problem. 
The performances of these methodologies are tested on the data set obtained from past 
blood donation activities in Ankara. In addition, GIS data of the European part of 
Istanbul is used as a constructed test case. The Pareto set of optimum solutions is 
generated based on blood amounts and logistics costs, and finally a sensitivity analysis 
on some important design parameters is conducted. 
 
Keywords: Mobile blood collection, Healthcare logistics, Selective Vehicle Routing 
Problem 
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Kan nakli birçok tıbbi işlemin en önemli kısımlarından biridir. Mevcut durumda, nakil 
için ihtiyaç duyulan kan ancak gönüllü bağışlarla sağlanabilmektedir. Dolayısıyla, kan 
bağışı sistemini verimli bir şekilde işleyebilecek şekilde yeniden tasarlamak büyük önem 
arz etmektedir. Bu çalışmada, Türk Kızılayı için, toplanan kan miktarını artırmak 
amacını güden bir kan toplama sistemi tasarlanmıştır. Tasarlanan sistem ayrıca 
operasyon maliyetlerini de ikincil bir amaç olarak değerlendirerek büyük miktarda kanın 
makul maliyetlerle toplanabilmesini sağlamayı hedeflemektedir.  
Mevcut sistemde Türk Kızılayı belirli aktivitelere(fuarlar, üniversite festivalleri vb.) kan 
toplama araçlarını göndermekte, bu araçlar ilgili günün sonunda, toplanan kanın 
bozulmaması için, topladıkları kanı belirli bir depoya götürmektedir. Kanın 24 saatlik 
dayanma süresini göz önünde bulundurarak bu şekilde tek bir noktaya günlük turlar 
düzenlenmesi sistemin yapısının bir gereği olarak görülebilir, fakat lojistik maliyetleri 
açısından bakınca verimli değildir. Önerilen sistem, var olan kan toplama araçlarının 
yanı sıra bir transfer aracının da sisteme eklenmesi ile her günün sonunda mobil kan 
toplama araçlarını ziyaret edip toplanan kanı kan merkezlerine taşımasını, böylece kan 
toplama araçlarının turlarına depoya günlük geri dönüşler olmaksızın devam 
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edebilmelerini sağlamaktadır. Kan toplama araçlarının duraklarına, her durakta 
beklenecek süreye kan toplama araçlarının ve transfer araçlarının rotalarına karar veren 
bir matematiksel model geliştirilmiştir. Literatürde bütün bu kararları beraber kapsayan 
bir çalışma bulunmamaktadır. Dolayısıyla, Seçici Araç Rotalama Problemi(SARP) için, 
Girişik Turlu SARP adında yeni bir version tanımlanmıştır. Ayrıca, aynı problem için 2 
aşamalı, tamsayılı programlama tabanlı bir sezgisel algoritma geliştirilmiştir. Bu 
yöntemlerin performansları, Ankara’da geçmiş kan toplama verileri kullanılarak test 
edilmiştir. Ek olarak, İstanbul Avrupa Yakası’nın Coğrafi Bilgi Sistemi verisi 
kullanılarak bir test problemi daha yaratılmıştır. Eniyi çözümlerin, toplanan kan miktarı 
ve lojistik maliyetine bağlı Pareto Kümesi hesaplanmış ve son olarak da bazı önemli 
parametreler üzerinde duyarlılık analizi gerçekleştirilmiştir. 
 
Anahtar Kelimeler: Mobil kan toplama, Sağlık Lojistiği, Seçici Araç Rotalama 
Problemi 
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Chapter 1  
 
Introduction 
Healthcare logistics is an emerging area of research with numerous studies that focus on 
important questions in different areas. In particular, the main subjects of healthcare 
related problems are ER room and doctor utilization, health care center location and 
medical supply transportation. These problems can be considered as trending topics 
because of the effects on people's lives as well as the computational challenges involved 
in their solutions. 
Blood donation logistics can be classified under the medical supply transportation 
problems as a healthcare logistics problem. Although blood transfusion is one of the 
most critical operations in various medical interventions, blood is a very limited 
resource. Since blood cannot be produced synthetically, the only source of it is 
donations. Annual demand on blood is 50 million units whereas the regular blood donors 
consist only 5% of the population. However, volunteer blood donations barely satisfy 
world-wide blood demands. Thus, people give blood in exchange of money which 
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increases the risk of transfusion-related-infections. The reason is that people, who sell 
their money, tend to lie about their medical conditions.  In order to raise the number of 
donors and their donation frequencies, effective use of bloodmobiles may be successful. 
Bloodmobiles can reach more people than those at fixed donation points, even the 
people with limited time and limited means of transportation.  
In this study, we propose a new mobile blood collection system for Turkish Red 
Crescent (TRC). The main motivation of this problem is that TRC faces shortage of 
blood regularly. Yet, the bloodmobiles are utilized as re-locatable fixed points not as a 
part of a mobile blood collections system. Therefore, this study focuses on designing a 
cost efficient and easy-to-implement bloodmobile system for TRC.  
In the current system, bloodmobiles visit some pre-determined activities such as fairs, 
college fests, and at the end of the day they return the depot to transfer the blood before 
spoilage. Blood needs to be delivered to an analysis and storage system (depot) in 24 
hours after the donation. However, this requirement causes the blood-mobiles to perform 
direct tours between the donation points and the depot. For activities that last more than 
one day, this application causes extra logistics costs. Because of the high costs, TRC 
does not consider to visit other points with relatively high donation potentials. With 
these shortcomings in mind, a new mobile blood collection system is proposed that 
consists of a transporter vehicle, called the shuttle, along the regular bloodmobiles. The 
main purpose of shuttle is to visit all the bloodmobiles in field at the end of a collection 
day and bring the collected blood to the depot. This approach enables the bloodmobiles 
to continue their tours without visiting the depot. The problem is determining the stops 
of bloodmobiles, the duration of each visit as well as the tours of the bloodmobiles and 
the shuttle.  
To the best knowledge of the authors', there does not exist a study in the literature that 
considers all the issues listed above. Doerner et al. propose the use of shuttles to bring 
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the collected blood to the depot, however, their model assumes the stops of 
bloodmobiles as fixed locations that are know a priori. Selective Vehicle Routing 
Problem (a.k.a Team Orienteering Problem) suggested by Chao et al. defines a way to 
select the stops of bloodmobiles and the routes of bloodmobiles, but the shuttle tours 
would be excluded with that approach. Therefore, a new problem called Selective 
Vehicle Routing Problem with Integrated Tours is defined in this study.  
In Chapter 2, blood donation and transfusion basics are summarized. Also, the evolution 
of blood donation operations is described shortly. Chapter 3, gives details on the 
bloodmobile systems all around the world and compares these systems with TRC. 
Basically, the shortcomings of TRC are listed and discusses.  
In Chapter 4, the problem that is discussed in this study is defined, related literature is 
addressed consecutively. This problem is related with different areas of the literature. 
First of all, the healthcare logistics literature is reviewed. Secondly, blood related 
logistics and supply chain papers are examined in order to understand the logistics 
dynamics that lies behind blood transportation processes. Finally, the selective vehicle 
routing problem and its extensions are discussed which inspires our solution 
methodology for this problem. 
Chapter 5 describes the mathematical model that is developed for this problem. Network 
design, cost and blood potential functions are also explained in detail. Also, the valid 
inequalities designed for the mathematical model are supplied.  
In Chapter 6, the performance of the mathematical model is tested on the data set 
obtained from past blood donation activities in Ankara. In addition, GIS data of the 
European part of Istanbul is used as a constructed test case. Also, some alternatives to 
the current depot location are compared.  The efficiency of suggested valid inequalities 
are also tested. The tradeoff between the amount of blood collected and the total 
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logistics cost is analyzed with the help of the Pareto efficient curves of Ankara and 
Istanbul instances. Finally a sensitivity analysis on some important design parameters 
such as the number of bloodmobiles and the blood potential estimation parameters is 
conducted. 
Chapter 7, describes the 2-stage IP based algorithm. Basically, this algorithm chooses 
the stops of the bloodmobiles according to their blood potentials in the first stage. Then, 
finds the tours of the bloodmobile and shuttle tours with the help of the MIP model that 
is described in Chapter 5. Computational times and optimality gap results of this 
algorithm are compared with the exact solutions that are obtained in Chapter 6. The 
thesis is concluded with a summary of the study and possible future research directions 
in Chapter 8. 
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Chapter 2  
 
Blood Transfusion & Donation 
Blood is a very critical component in human life. However, in today's conditions 
scientists are not able to produce blood synthetically. That is, the only source of blood is 
other human beings so blood transfusion has a significant role in today's healthcare 
operations. In United States the need for blood is about 10 million units per year. In 
Germany and Japan, the annual demand is nearly 4 million units in both countries. 
Turkish Red Crescent estimates Turkey's blood need to be above 1.5 million units in 
2011 [1]. All these demands can be satisfied by successful blood donation & transfusion 
operations only.  
2.1 Basics 
Blood is composed of red and white blood cells, plasma, platelets and proteins. The 
main function of blood is regulating the carbon dioxide-oxygen metabolism. Also, blood 
transports oxygen, nutritious elements and hormones to the tissues while it brings back 
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the carbon dioxide and toxic elements to the lungs and kidneys for removal [2]. Other 
than these functions, blood circulation helps to maintain the pH value of the blood in the 
desired level and controls the body temperature. 
These critical functions are performed by the different components of blood. We can 
summarize the components of the blood as in Figure 2-1. 
 
Figure 2-1 Components of blood 
Plasma is the liquid part of the blood and constitutes 55% of the blood. The main 
function of plasma is transportation of water and water-soluble materials such as 
minerals, hormones, urine and vital proteins.  
Remaining %45 of blood is composed of blood cells, mainly, red blood cells 
(erythrocytes), white blood cells (leukocytes) and platelets (thrombocytes). Figure 2-2 
summarizes the basic characteristics of the blood cells: 
Blood
Cells
Red Blood 
Cells
White Blood 
Cells
Platelets
Plasma
Water, 
nutrients, 
chemicals
7 
 
 
Figure 2-2 Characteristics of blood cells 
[http://www.nsbri.org/humanphysspace/focus3/earthphys-frame.html] 
A healthy adult carries about 5-6 liters of blood and an average adult can easily handle a 
loss of 500 ml. of blood without a transfusion. On the other hand, if a person loses 
between 1000-1500 ml blood in short amount of time or some blood components 
(platelets, red blood cells) are below the required levels because of a disease (cancer, 
anemia etc.) or an operation, he needs a transfusion operation.  
In most of the cases blood transfusion is used as a temporary therapy. In those cases one 
patient may require several units of blood, but as soon as the threatening situation 
(operation, shock etc) disappears, the blood transfusion may be terminated. On the 
contrary, some patients need blood donation as long as their disease is cured or even as a 
life-time. The well-known diseases that require a life-time blood support are: Cooley's 
anemia, anemia, hemophilia and leukemia [3]. 
Even though, some operations still require whole blood transfusion, most of the donated 
blood is decomposed after the donation and required blood products are transferred to 
the patients. With this approach, the patient does not receive unnecessary components 
and also from a single unit of whole blood more than one person may benefit. Also, the 
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shelf-life of the blood-components are longer than the whole blood. In particular, whole 
blood can stay without perishing up to 24 hours whereas red blood cells, plasma and 
platelets remain fresh up to 42, 60 and 5 days respectively [3]. For this reason, making 
use of blood components is more preferable that storing whole blood units. There are 
two main process that is used to obtain blood components. First one is centrifuge, which 
is the process of spinning blood samples around a center so that the components with 
different density will separate from each other. Centrifuge is applied to the blood units 
that are collected in classic way. (Figure 2-3) In whole blood donation, the donor's 
vessel is connected to a plastic bag and with his blood pressure the blood is collected in 
a plastic bag. In one donation session one person can give up to 500 ml.(1 unit) of whole 
blood. 
 
Figure 2-3 Standard blood donation via plastic bags 
The second way of separating blood components is apheresis. (Figure 2-4) In apheresis 
therapy, the donor connects an apparatus, and this apparatus takes his blood, 
decomposes the required component from the blood and gives the rest of the blood back 
to the donor.  
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Figure 2-4 Apheresis donation 
This method has some advantages over the classical whole blood donation. First of all 
the donor receives some parts of his blood back. Also, in one apheresis session one 
donor can donate platelets that are equivalent to up to 6-8 whole blood donations. In 
addition to these, apheresis can be applied more frequently than whole blood donation. It 
is suggested that one gives a break of 6 months between two whole blood donation 
sessions. However, one can donate platelets with apheresis bi-weekly. On the contrary, 
apheresis methodology has its shortcomings as well. First of all, apheresis machine is 
not a portable design, and so it is not possible to utilize such a device in bloodmobile 
tours. This is an important problem because mobile blood donation constitutes a very 
significant part of the overall blood donation amount. Also, apheresis procedure lasts 
around 2 and a half hours where standard whole blood donation takes at most half an 
hour. Finally, apheresis seems frightening to most of the donors since it requires 
connecting a large machine and sitting still for about 2 hours. Considering all these 
reasons, blood collectors mostly prefer to pick up whole blood from the donors and 
obtain the blood products later with centrifuge. 
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Once the blood is collected from the donors it is brought to some special center where 
several tests will be performed on the whole blood. Since the shelf-life of the whole 
blood is very short the distance between the donors/donation centers and the testing 
center is an important issue to handle. All around the world the tests that are performed 
on collected blood are more or less the same. First the blood is tested for infectious 
diseases such as: anti-HIV test, anti-HCV (Hepatitis C) test, HBsAg test (Hepatitis B), 
syphilis test etc. Then, blood type test are performed and blood units are labeled 
accordingly.  
The main blood groups are A, B, 0 and AB. The A and B is the name of two different 
proteins that is carried in red blood cells. If a person carries both of them in his red blood 
cells his blood type is AB and carries none of them, then his blood type is classified as 0. 
One person's plasma contains the antibodies of the proteins that he does not carry. 
Therefore, a person with 0 blood type carries antibodies for both A and B proteins and if 
he receives a blood type other that 0, the plasma in his body will react to the proteins in 
donors blood. In addition to this classification bloods are also categorized as Rh positive 
or Rh negative whether or not they carry Rhesus factor. The same logic with the blood 
type proteins is applicable to Rh factor. A person with Rh- blood type cannot receive 
blood cells from a Rh+ donor.  Table 2-1 shows the red blood cell compatibility chart of 
the blood types.  
Table 2-1 Red blood cell compatibility chart 
 
 On the other hand, the plasma transfusion has the opposite rules since the antibodies are 
carried in the plasma. For instance, a 0 
and AB blood type donors since a person's plasma with 0 blood type contains antibodies 
of both A protein and B protein. The plasma compatibility amon
Table 2-2. 
The distribution of these blood units are not even among people, some blood types are 
rarer than the others. However, the 
For instance the distribution
2-5. 
Figure 2-5 Population distribution among blood types in Turkey and UK
B Rh -
2%
0 Rh +
29%
0 Rh -
4%
AB Rh +
7% Turkey
11 
blood type patient can receive plasma from A, B 
g blood types is as in 
Table 2-2 Plasma compatibility chart 
 
ratios vary from nation to nation or region to regi
s among the blood types in Turkey and UK are
A Rh +
36%
A Rh -
5%B Rh +
16%
AB Rh -
1%
B Rh -
1%
0 Rh +
40%
0 Rh -
7%
AB Rh +
2%
AB Rh 
1%
UK
on. 
 as in Figure 
 
 
A Rh +
36%
A Rh -
6%B Rh +
7%
-
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After all the disease and blood type testing are completed, the centrifuge phase starts. 
The centrifuge process may or may not take place at the same facility that the testing 
phase is performed. However, in many systems the storage of the centrifuged blood is 
handled in the same facility that centrifuging takes place.  
 
Figure 2-6 Phases of centrifuge operation 
In this stage, one unit of whole blood (Figure 2.6.a) is first mildly centrifuged in order to 
distinguish the plasma from the blood cells (Figure 2.6.b). In this stage, plasma contains 
platelets. This plasma and platelet mixture is taken to another bag (Figure 2.6.c). The 
remaining part constitutes of red blood cells and called red blood cell suspension. This 
suspension is mixed with a protective solution and kept in special fridges between +2 ̊C - 
+6 ̊C. The shelf life of this red blood solution is 42 days. The plasma with platelets is 
centrifuged again and the platelets subsides (Figure 2.6.d).  
After this second centrifuge, the obtained plasma is taken to another bag and frozen 
(Figure 2.6.e). Plasma remains fresh up to 3 months, if it is kept between -18 ̊C - -25 ̊C. 
The bag that contains the platelets is kept between +20 ̊C - +24 ̊C in a special machine 
13 
 
which gives a continuous vibration. Under these conditions, the platelets will not perish 
before 5 days.  
2.2 Evolution of Blood Transfusion & Donation 
Blood donation operations evolved in 17th century and up until now, this concept 
preserves its importance in healthcare operations. With technological developments and  
improved equipments the blood donation and transfusion operations progressed 
significantly.  
Before the first successful blood transfusion between humans, there were many 
successful and failed attempts between animals, from animals to humans and from 
humans to humans. In 1667, the first successful transfusion from sheep to human is 
performed by Jean Baptiste Denis in France. However, many unsuccessful attempts and 
resulting deaths caused Paris Society of Physicians to outlaw any kind of blood 
transfusion.  
Dr. James Blundell is known for the first successful human-to-human blood transfusion 
in 1818. Many scientists try to figure out what goes wrong in some transfusions which 
are performed in very similar conditions with the successful ones. In 1901, Karl 
Landsteiner came up with a very critical answer to this question when he discovered the 
first three main blood types (A, B and O). One year later, AB blood group is found by 
Decastrello and Sturli.  
During the World War I, the importance of blood transfusion grew dramatically. As a 
result, related scientific studies became more crucial. The main problem, that the 
scientists focused on was to keep blood fresh during the transportation to the battlefield 
and maintain it in field hospitals a little bit longer. Scientists suggested a breakthrough 
methodology, mixing the collected blood with sodium citrate, to prevent blood to perish 
quickly. With this new approach, the old blood transfusion methodology that requires 
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the donor and the receiver to be in the same room simultaneously is vanished and also 
pioneered the technologic improvements that make blood-banking possible. Another 
important discovery belongs to WWI era is frozen blood. Scientists found that 
refrigerated blood stays longer. 
As well as the technological developments, management of the blood donation and 
transfusion processes become more organized after WWI. Blood transfusion operations 
performed more commonly for patients other than war victims as well. British Red 
Crescent founded the first human blood transfusion center in 1921. In 1932, the first 
facility that can be classified as a blood bank started to operate in Leningrad Hospital, 
Russia. Dr. Bernard Fantus established the first blood bank of United States in 1937.  
During the years 1939-1940, the RH blood system was discovered and recognized as the 
major reason of the complications that occur the blood transfusion operations after the 
discovery of major blood types. As a result, ABO and RH identification tests were 
applied each unit of blood until 1947. Also, syphilis tests performed to the transfused 
blood and this test pioneered many similar disease tests that are performed today. 
In 1950, Carl Walter and W.P. Murphy suggested to use plastic bags instead of the glass 
bottles to carry collected blood. This development yielded easier and safer transportation 
of the collected blood and enabled today's bloodmobile technology. Additionally, plastic 
bags are easier to handle in centrifuge processes so, with the use of plastic bags 
obtaining multiple blood products from a single unit of blood came into the picture.    
After 1954, blood transfusion started to be used for different disease therapies other than 
hemorrhage such as hemophilia, chicken pox, cancer etc. With the widespread use of 
blood transfusion, the disease detection tests gained importance. Starting from 1971 
many disease tests such as Hepatitis B-C, HIV 1-2, anti-HLTV-1, etc, are added to the 
list. 
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Chapter 3  
 
Blood Donation Logistics 
3.1 Blood Donation Logistics in the World 
There are 187 Red Cross and Red Crescent societies all around the world and these 
societies are the main blood suppliers and disaster response coordinators in their 
respective countries of operation. All these organizations are united under the 
International Federation of Red Cross and Red Crescent Societies (IFRC) [4]. This 
federation aims to help people in need at time of wars, terrorist attacks, natural disasters 
etc. This federation also facilitates communication among these societies and in turns 
enables quick and effective response respond to the large-scale incidents when the 
national society falls short of doing so. For instance, IFRC was one of the first and most 
effective respondents of 2005 Pakistani Earthquake, in which many Red Cross/Crescent 
societies all over the world prepared and delivered the medical supplies, shelters and 
other urgent needs very quickly in a very well organized manner. 
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Although, the IFRC members act as a team in major incidents, their organization 
structures are slightly different when it comes to national problems. Yet, their missions 
and visions are basically the same. In general, they are main disaster response 
organizations and blood collectors in their country. 
World Health Organization (WHO) states that blood transfusion from volunteer blood 
donors to patients is the safest way. For this reason there are many European countries 
that forbid giving blood in exchange of money. If a person sells his blood for monetary 
gain, he may have reason to lie in respond to the questions regarding his medical history, 
sexual habits and other critical medical issues. Infection tests are performed for every 
unit of blood that is received but these tests have error factors, hence the answers of 
these questions may be as important as the test results. Since Red Crescent and Red 
Cross receive blood only from volunteer donors, they are considered to be not only the 
largest but also the safest national blood suppliers in the countries of operation.  
On the other hand, there are still many countries where sale of blood and blood products 
is legal. According to WHO's report, 42 countries can supply only up to 25% of their 
blood needs from unpaid volunteer donors. [5] 
As one can deduce from Figure 3-1, most of the countries in South America, Africa and 
Asia have unpaid blood donation rates below 90%. When it comes to blood products 
such as plasma, the picture is even worse. For instance, in the US selling plasma is legal 
even though blood needs of the country are satisfied entirely by volunteer blood 
donation. In China, many people sold their blood for cash in mid-90's and there was a 
large scale HIV spread observed back then. [6] 
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Figure 3-1 Percentage of voluntary blood donation 
American Red Cross itself, supplies nearly 40% of the national blood supply (12 out of 
30 million units of blood products annually). [7] The rest of the demand is covered by 
the hospitals' blood transfusion units/banks, and the third parties which take blood 
products from blood-sellers and convey them to the patients. 
Red Crescent and Red Cross Societies all over the world share the same organization 
structure for their blood collection units. These units consist of mainly fixed points (such 
as blood centers, hospitals and cliniques) and bloodmobiles. A bloodmobile is a vehicle 
(usually a bus or a large van) containing necessary equipment for the blood donation 
procedure. Blood drives involving bloodmobiles usually happen in public places such as 
colleges and churches. These drives aim to reach at numerous donors that may not be 
planning to make a blood donation otherwise.  
In a well developed blood collection system, the majority of the collection procedure is 
performed by the bloodmobiles. The fixed locations mainly focus on testing and storage 
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of the blood and also serve as a depot until the transportation of the blood to the demand 
points. In addition, fixed locations serve as a base for the apheresis type procedures 
which are too complicated to be performed in a bloodmobile. About 80% of the 
donations collected by American Red Cross are performed in bloodmobiles, whereas 
only the remaining smaller part takes place in fixed points. ARC completed 200.000 
bloodmobile tours annually where 50.000 of them are sponsored by companies, schools 
and organizations.[7] An individual donor can find the nearest bloodmobile tour in the 
proximity of a selected location on a given date by providing the ZIP code to the website 
of ARC. It is possible to make an appointment for a bloodmobile tour through the 
interface shown in Figure 3-2. 
 
 
Figure 3-2 Blood drive appointment interface in the website of ARC 
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Instead of attending an independent bloodmobile tour, one can arrange a specific 
bloodmobile tour for his school or company as well. That is called sponsored blood 
drive. It is very easy to host a blood drive as a sponsor. All the sponsor needs to do is to 
arrange a suitable place (a school garden, a parking lot etc.), recruit donors by 
announcing the organization and complete a simple form.  
The US has a very well designed bloodmobile system. Similarly, Canada, United 
Kingdom and Singapore has significantly well-designed blood collection systems with 
well-operating bloodmobile components. In the next section, we will take a look at 
blood collection units of Turkish Red Crescent (TRC) and explain the similarities and 
the differences of TRC with other similar societies. 
3.2 Blood Donation Logistics in Turkey 
In Turkey, blood collection operations are mainly performed by Turkish Red Crescent 
which is also a member of IFRC. TRC operates 55 blood collection centers in 51 cities 
around Turkey and provides nearly seventy per cent of the national blood supply. The 
organization is responsible for collecting blood from voluntary blood donors, analyzing 
the collected blood and transporting it to the demand points such as hospitals. On the 
other hand, TRC provides services not related to blood transfusion/donation such as 
disaster management, humanitarian help and education on disaster response. 
After the Istanbul earthquake in 1999, TRC started a nationwide blood donation 
campaign, since the stocks in blood banks fell below the critical levels. The goal was 
collecting 1.5 million units of blood and the target was achieved with the help of 
community sense. Since then, the campaign repeated periodically to keep the stocks 
ready for a potential disaster as well as the satisfaction of the regular demand. After the 
announcements of the campaign, mobile units become significantly important since they 
can reach at even those with limited means of transportation. Still, the mobile blood 
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collection is not the major part of blood collection in Turkey unlike the other countries 
in the world. TRC performs blood collection operations via fixed locations and with the 
help of a mobile system. Their structures and operational mechanisms can be 
summarized as follows:  
- Fixed Locations: Regional Blood Centers (RBC), less developed Blood Centers 
(BC) and supporting facilities known as Blood Stations (BS) are the three types of fixed 
locations. RBCs are capable of performing every blood related action such as collection, 
analysis, storage, distribution etc. The coordination of activities in BCs and BSs are also 
among the responsibilities of RBCs. BCs, which are more common, can also perform 
basic analysis and storage as RBCs. BSs support only the collection and temporary 
storage of blood that is brought by the mobile units. Disease and blood type analysis 
needs to be performed at RBCs or BCs. The demand points are fed from these centers in 
the desired amounts only after the analysis process is completed. Each mobile unit is 
assigned to either a BS or BC, thus mobile blood tours are originated from these centers. 
In the system that is described by Şahin et al. [8] there are 7 RBCs, 23 BCs and 34 BSs. 
The proposed hierarchy in Şahin's study can be seen in Figure 3.3. 
 
Figure 3-3 Hierarchy of TRC 
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- Bloodmobiles: Mobile Systems provide an effective way to contact with volunteers by 
arranging their tours according to social events or company calls. In Turkey, 
bloodmobiles provide service at pre-arranged temporary locations such as governmental 
organizations, municipalities and certain public events, where the potential number of 
donors is large. Pre-determined locations are visited by bloodmobiles according to a 
yearly prepared scheduled. However, they do not perform regular tours to distant 
locations. In the current system, bloodmobiles perform independent direct tours to the 
locations where public events take place or company campaigns. In Figure 3.4, one of 
the bloodmobiles during a collection activity can be seen. 
 
Figure 3-4 A bloodmobile of TRC 
Locations and dates for mobile blood collection are usually determined by the host 
organizations and TRC. TRC assigns collector teams to these host organizations on the 
designated days. After the collection process the collected blood needs to be sent to the 
closest RBC/BC for analysis and storage at the end of each day due to the perishable 
nature of whole blood because shelf life of whole blood is 24 hours. Although, the whole 
blood deteriorates very quickly, the blood components can be stored significantly long 
terms with the help of chemicals and special storing conditions as described in the 
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previous chapter. At the end of each day, bloodmobiles return to the RBC/BC (depot) to 
which they are assigned to for preventing early blood spoilage. If the activity or 
campaign is a 2 or 3 day one, the bloodmobile comes to this point in the morning and 
goes back to depot at the end of each day. One good example of 3 day long blood 
donation activities is college fests. If there is not a pre-arranged donation activity the 
bloodmobiles stay idle in the depot (corresponding blood center/ blood station). 
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Chapter 4  
 
Problem Definition & Related Literature 
4.1 Problem Definition  
Observations on the blood donation systems of those countries which cover their blood 
donation needs entirely by voluntary blood donation suggest that a successful mobile 
blood donation system may significantly increase the donation volumes.  
TRC aims to improve blood donation volumes considering the annual demand increase. 
As an NGO that has a limited budget, it needs to do so while keeping operational costs 
in a reasonable level. Fixed blood collection units are utilized considerably well in 
Turkey. However, the mobile units are not utilized well. They show up only in very 
large public events which are rather rare. Other than that, they wait in the depot or in 
front of malls and serve as temporary fixed points. Even though, their visits to malls 
seem as reasonable choices, people are usually too busy to take time for donation. Also, 
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the potential donors realize that there is a bloodmobile only after they reach that point. 
Hence, they do not have time to prepare themselves to make a successful donation. If a 
person intends to donate blood, he needs to stop smoking temporarily and taking drugs 
and alcohol 24 hours before the donation. In addition, he should not do sports on the 
donation day. However, a person who comes up a bloodmobile incidentally may not 
satisfy these conditions. Despite the fact that visiting crowded places in weekends carry 
a high potential, this arrangements do not yield high donation rates.  
Another problem of the current blood collection system is the fact that bloodmobiles 
performing independent direct tours to activities which last longer than one day. Also 
they sometimes omit the second or the third day of the activity. There are two problems 
with this application. If a bloodmobile performs a direct tour instead of simply waiting 
for 2 days in that place, the transportation cost is doubled. Yet, if the crew chooses to 
skip the second or third day of the activity, they lose the opportunity to collect a 
significant amount of blood donation because most of the people focus on the ongoing 
activity on the very first day. It is also more likely that they hear about a bloodmobile 
after the first day. These are the shortcomings of direct blood mobile tours. However, the 
collected blood needs to be carried to a blood center at the end of each day before the 
blood perishes as explained in Chapter 2. 
Instead of improving the current blood mobile system, we design a new mobile blood 
collection system for TRC that overcomes all symptoms that are described above. The 
new system basically allows 2 or even 3 day stay-overs, while conveying the collected 
blood to the depot still on time. The new system also proposes more frequent and 
utilized bloodmobile tours with a weekly schedule. The routes are not completely based 
on special, large-scale events but instead; smaller towns and suburban places will be 
visited as well. 
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The proposed system consists of current blood mobiles and an additional shuttle per 
depot. The bloodmobiles start their tours at the beginning of the planning horizon and 
they may not come back until the last day. They will visit several potential locations 
once they leave the depot and spend at least one day for each stop. If the estimated blood 
potential of a location is significantly high, the bloodmobile can stay overnight in there 
without returning to the depot. With the help of the new shuttle service the redundant 
tours between the location and the depot are eliminated, since the shuttle will visit every 
bloodmobile in the field at the end of each day and transport the collected blood to the 
depot. In this case, the crew of the bloodmobile needs to go their houses themselves. 
Yet, this is not a problem since potential stops of bloodmobiles are easy to reach for 
people. The only exception is the end of a bloodmobile tour because bloodmobile also 
comes back to the center and for this reason; shuttle’s visiting that bloodmobile at the 
end of the planning horizon is redundant. An example of shuttle and bloodmobile tours 
can be seen in Figure 4.1. Figure 4.1.a represents the potential stops of the bloodmobiles 
and the depot. In Figure 4.1.b, the tours of 3 bloodmobiles are given, the self loops 
correspond to stay-overs. In Figure 4.1.c, the labels of the bloodmobiles correspond to 
days that they are visited by a bloodmobile. The Figures 4.1.d, 4.1.e and 4.1.f show a set 
of potential shuttle tours belonging to the first, second and third days of the planning 
horizon.  
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Figure 4.1.a                                                               Figure 4.1.b 
 
Figure 4.1.c                                                               Figure 4.1.d 
 
Figure 4.1.e                                                               Figure 4.1.f 
Figure 4-1 An example of bloodmobile and shuttle tours in the proposed system 
With this new system we aim to utilize unused bloodmobiles, increase the frequency of 
bloodmobile tours, reduce the operational costs of mobile blood collection system and 
gain regular donors. Our approach that will be discussed in the next chapter aims to: 
- choose the locations that bloodmobiles visit among possible candidates, 
- determine the length of the stay on a visited location by bloodmobiles, 
- sequence the chosen locations in tours of bloodmobiles and 
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- build the shuttle tours based on stops of bloodmobiles in the field for each day of the 
planning horizon, 
while maximizing the collected blood amount and minimizing the transportation costs of 
the vehicles. Since the stops are not known a priori and we need to define the tours 
between stops that are chosen among potential places, our problem can be classified as a 
variant of Selective Vehicle Routing Problem, which will be detailed in the following 
section. The stops of shuttle tours are determined according to bloodmobile stops and at 
the same time we need to come up with the least cost shuttle tour as well. This setup 
yields considering interdependent bloodmobile and shuttle tours. Hence, we named our 
problem as Selective Vehicle Routing Problem with Interdependent Tours (SVRPwIT). 
To the best of the authors’ knowledge this variant of Vehicle Routing Problem has not 
been defined in the literature.  
 
4.2 Related Literature 
OR Applications in health care logistics operations has an increasing trend in recent 
years. Several OR practitioners focus on health related problems such as emergency 
room and doctor utilization, health care center location and medical supply 
transportation. Health related transportation problems are deeply investigated because of 
their complicated nature brought by the simultaneous consideration of medical 
constraints and challenging transportation dynamics. 
In his analysis Jarrett [9] summarizes these new trends in international healthcare 
logistics and makes comparisons in a global scope. The author gives details on several 
implementations of just-in-time (JIT) approach in health-logistical environment. Since 
these methods are already adopted in industry for a long time-period, he also compares 
these two application areas in terms of advantages and disadvantages. He summarizes 
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several real-life examples both from the industry and the healthcare sector and points out 
the differences between the JIT implementations in these two areas. 
Brandeu et al. [10] covers a set of different operations applications in different areas. 
While doing so, they attach these issues to current health care problems and possible 
future challenges. As a result of limited resources today's major healthcare delivery 
problems occur in low and middle-income countries. Malnutrition and related infectious 
diseases, insufficient vaccination, absence of affordable essential medication are at the 
top of the list. Surprisingly, on the other hand, health care delivery systems are not 
perfect in most of the high-income countries. The main reason for this is ineffective 
usage of resources.  It is also indicated that the health care accessibility will still remain 
limited in the future even though many improvements are achieved. The book covers the 
relevant studies under three main sections: namely, healthcare operations management, 
public policy analysis and clinical applications. 
Problems that are based on healthcare logistics consider equity as one of the major 
objectives besides the operational costs and as Brandeu's projections point majority of 
the healthcare problems will occur on low income countries. There are different studies 
on providing healthcare services to the poor and unhealthy people in developing 
countries. Considering the healthcare infrastructures and geographical conditions in low-
income countries, especially in Africa, scientists develop different approaches of 
providing health services while respecting to equity. In their study, Hodgson et al. [11] 
search for ways of increasing the accessibility of primary health care resources in Suhum 
District of Ghana and in order to do so, they decide to utilize mobile healthcare facilities. 
In their study, they solve a Covering Tour Problem (CTP) to find the 'best' tour for the 
mobile healthcare facility. In particular, they find the shortest tour which has at least one 
stop in a certain radius of each population center. They also consider the rainy and dry 
seasons while determining parameters. The paper suggests an exact algorithm for small 
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instances and an insertion based heuristic for larger ones. The accessibility of primal 
health care increased up to 99%, where it was only 30% before this study. 
Doerner et al [12] focus on a similar problem in Senegal. However, instead of solving a 
CTP they come up with a different model which combines three objectives: tour cost, 
average distance a member of the population to the nearest stop and coverage of 
population. They suggest three solution strategies. One is to compute the Pareto-
optimum solution sets and the other two are variations of genetic algorithms for multi-
objective problems. 
Since blood is hard to obtain and it easily perishes, blood product management is one of 
the very interesting and challenging healthcare problems. There are many studies 
conducted in this subject. Belien and Force [13] classify blood supply management 
studies in their survey. One can easily observe the increasing attention on this subject 
after year 2000 by examining the charts on this paper. In their survey, the authors solely 
focus on inventory management studies of blood products. This paper is a very up-to-
date study, which summarizes what kind of problems are faced in blood banking and 
during blood transportation from blood storages to the demand points etc. 
For instance, Pierskalla's [14] study is a comprehensive analysis on the supply chain 
operations of blood banking. In this paper, the author starts with stating the major 
decisions in a blood bank environment such as the number and locations of blood 
centers in a region, the supply and demand coordination and the assignment of donor 
areas to transfusion centers. The transshipment operations of the blood between blood 
centers or even depots in the demand points are considered in details. Consequently, the 
paper contains a good analysis on inventory management of the collected blood. As a 
real-life aspect of the study, it provides significant statistics on supply chain 
management of blood banks and analyzes currently-in-use blood banking models in US. 
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Similarly, Hemmelmayr et al. [15] discuss delivery and storage strategies for Austrian 
Red Cross and they investigate whether a vendee (hospitals) or a vendor (blood bank) 
based inventory setting is better. Satisfying demand in transfusion centers with 
minimum amount of blood perished is the main objective(s) of the logistics department 
of Austrian Red Cross. They seek the best delivery strategy in order to meet the needed 
blood. Their first strategy consists of a bunch of fixed tours with an MIP model that 
chooses the schedule of the tours. Their second option combines flexible tours with a 
regular schedule for visits. 
Delivering blood products from blood banks or suppliers to hospitals is only one aspect 
of this problem. In many cases, redistributing the blood between the hospitals is also 
necessary for preventing outdating. If there is an urgent need of a specific blood type in 
a hospital, they may want to use the blood with closer spoilage date from another 
hospital. The reason is even one unit of blood spoilage is not tolerable, especially if it is 
a rare blood type. However, this approach requires a well planned and dynamic storage 
management. In their study, Kendall and Lee [16] concentrate on this redistribution 
problem. Their model has different objectives, such as prevention blood shortages and 
overages in hospitals, minimization of the number of outdated units, maintaining the 
average age of blood products at an acceptable level and minimization of the operating 
costs. The authors use goal programming to solve this problem with conflicting 
objectives. 
These four studies are interested in the operations after arrival of the donated blood at 
the blood banks and/or hospitals. However, blood donation supply chain is much longer 
if we consider all the steps from the first supplier (donor) to the last customer (receiver). 
If the blood donation takes place in a fixed location, then there will not be extra 
operations to consider in the supply chain context because these fixed points are 
generally part of either a blood bank or a hospital. However, blood may be collected by 
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a bloodmobile. As a result, many questions about rotations, tour durations and other 
logistic issues come into the picture.  
Despite many countries’ major blood donations are performed via mobile points, there 
are few studies on bloodmobile operations in the literature. In Turkey, using 
bloodmobiles in a systematic way is first suggested in Sahin et al.[8]'s study. This study 
is one of the very few studies that help the re-building process of Turkish Red Crescent 
after the 1999 Golcuk and Duzce earthquakes. In this study, the authors propose a new 
hierarchy for TRC's blood services. The suggested hierarchy consists of small but 
widely distributed blood stations, high-tech equipped blood centers and regional blood 
centers and finally mobile units. As a second stage of the study they determine the 
locations of these components of the suggested system with a help of pq-median location 
model, which is an extension to the classical p-median problem. This model includes 
two integrated p-median problems; it first chooses locations of p (regional) blood centers 
and then locates q blood stations and assigns them to the opened blood centers.  
Using bloodmobiles effectively is also very important. Launching a bloodmobile station 
is not enough; every step should be designed carefully. If the ongoing processes in a 
bloodmobile are slow and unorganized, it may miss the opportunity to fully serve a point 
with high blood potential in the allotted time window and in turn may result in the loss 
of many future potential regular donors. With this motivation, Brennan et al. [17] and 
Alfonso et al. [18] focus on reducing operational times in a bloodmobile. They both test 
their suggested layouts and strategies using simulation with different customer arrival 
patterns and behaviors.  
Doerner and Hartl [19], [20] focus on health care logistics problems in a disaster relief 
context. They describe routing problem issues that arise in emergency preparedness and 
give several models for ambulance location and routing problems, disaster response 
problems as well as blood transportation. They keep the main focus on Austrian Red 
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Cross (ARC) healthcare operations and use real data obtained from ARC. In particular, 
their research focuses on blood collection with the utilization of mobile blood collectors 
as one aspect and transportation of the collected blood to the demand points as another. 
The suggested system includes extra transporters to take the blood from the mobile 
campaign teams in addition to regular bloodmobiles of the campaign. The extra 
transporters are added to the system in order to carry the blood from the bloodmobiles to 
the analysis center before it perishes. The locations of bloodmobiles are assumed known 
and fixed. They define a time window based on the lifespan of the collected blood from 
the donors and so, define ARC's problem as a Vehicle Routing Problem (VRP) with 
multiple interdependent Time Windows. Finally, the paper concludes with a periodic 
VRP problem defined for periodic blood supply to demand points (hospitals).  
While designing bloodmobile tours, the planner should consider the amount of potential 
locations as well as the operational costs. Since the number of potential locations can be 
excessive and planning horizon or estimated budget is limited, visiting all these stops is 
not practical in real life. Therefore, choosing a subset of these locations as tour stops is 
very reasonable. These kinds of routing problems are classified as the Selective 
Travelling Salesperson Problem in the literature. These types of problems have two 
major objectives: minimizing the tour cost and maximizing the profit that is obtained 
visiting those nodes. Although, the main motivation is determining the subset that is to 
be visited, what varies in general is the selection of the objective function and the 
constraint with a desired achievement level of the other consideration. If these two 
objectives are combined in the objective function then the problem is called the 
Profitable Tour Problem (Dell'Amico et al. [21]). On the other hand, if the objective is 
defined as maximization of the collected profit (blood) and a pre-determined cost level is 
given as a constraint, then it is classified as Orienteering Problem (a.k.a TSP with profits 
- Laporte and Martello [22] or maximum collection problem Katoka and Morito [23]). 
Finally, if a problem is defined with a cost minimization objective and a pre-determined 
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profit lower bound in the constraints, it is considered as a Prize Collecting Travelling 
Salesman problem, which is defined by Balas [24]. In their study Feillet et al. [25] 
compares all these three approaches in detail. They also give real life applications 
related to this problem and summarize exact and heuristic solution procedures of them.  
These three approaches assume that the profit is ready to be picked up, once the vehicle 
visits that location. However, the real situation might not be this simple. The profit may 
depend on surrounding districts of the stop and the distance between the stop and the 
districts may affect the value of that stop. Also, customers may want to choose the stop 
at which they get service. In their study, Erdogan et al [26] consider these new 
constraints and define a new problem called the Attractive Travelling Salesperson 
Problem. Their problem has two different vertex sets customers and potential stops. The 
value of each stop is determined by a function that depends on population and distance 
of the surrounding customers. The developed model decides which customers will be 
assigned to which stops while determining the subset of stops that are visited by 
salesperson. The authors develop a branch and cut procedure for this problem as well as 
a tabu search algorithm. 
Vansteenwegen et al [27] is a very recent survey on the orienteering problem. In this 
paper, the authors classify all variations of the orienteering problem with a deep insight 
on new exact and heuristic solution procedures. The study also considers team 
orienteering problems, which have the same definition with the exception of using 
multiple vehicles instead of a single one. The team orienteering problem is an important 
concept especially in the context of our study because using only one vehicle may not be 
an effective approach to model bloodmobiles especially in a metropolis. 
Team orienteering problem is defined by Chao et al. [28]. In this study they model the 
orienteering problem, which is defined previously, for the multiple vehicle case. In 
general, this problem is referred to the Selective Vehicle Routing Problem from now on.   
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Combining multi-objective approach with multi vehicle routing problems is important 
and there are several studies on this subject. Jozefowiez et al. [29], [30] concentrate on 
this problem. In particular, the second paper gives a detailed taxonomy on multi-
objective vehicle routing problems. However, the studies that are discussed in these two 
papers have classical vehicle routing approaches, in which the vehicles need to visit all 
vertices in a given problem. This is not applicable to the case that is discussed in our 
study.  
In their study Archetti et al. [31] considers capacitated selective VRP problems. They 
develop models for both Capacitated Profitable Tour Problem with multi-vehicle 
(maximizing profit with a given cost upper bound) and Capacitated Team Orienteering 
Problem (both the cost and the profit component is combined in the objective). Then, 
they develop tabu search meta-heuristics for these two problems.  
Another variation of the Capacitated Selective Vehicle Routing Problem (CVRP) is 
defined by Aksen and Aras [32]. The authors also add a time deadline for each customer, 
and if the vehicle visits that customer after the deadline, it gains no profit. The paper 
provides a MIP formulation for this problem as well as a 2-stage iterative heuristic 
methodology. In the first stage a simulated annealing algorithm is adopted to find tours 
for the classical CVRP problem on the instance. In the second stage, the algorithm 
decides on the nodes that are to be discarded according to their profit and deadline 
values. Basically, the second stage transforms a CVRP solution to a Selective CVRP 
solution with time deadlines. 
Valle et al. [33] come up with an interesting variant of the Selective VRP problem. They 
define their problem with a pre-specified profit constraint, but instead of minimizing all 
tour lengths, they minimize the length of the maximum tour. The authors propose a 
branch and cut algorithm (BC) and a local branching (LB) algorithm for the instances 
with a small number of vehicles. For large instances, they develop a GRASP (Greedy 
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Randomized Adaptive Search Procedure) based algorithm to improve the bounds that 
are obtained by BC and LB. 
Sural and Bookbinder[34] define a variant of Vehicle Routing Problem with backhauls 
where the backhauls can be performed for a subset of the demand nodes according to 
their profits. Therefore, the backhaul tours of this problem can be classified as Selective 
VRP tours. They develop an MILP for the problem and lift the Miller-Tucker-Zemlin 
subtour elimination constraints accordingly. 
The selective VRP approach is very suitable for determining the bloodmobile tours. It 
takes into account unvisited potential stops and multi-objective nature of the problem. 
However, once a bloodmobile visits a location it should stay there for at least one whole 
day because of the set up costs and blood donation campaign's features. Also, 
independent direct tours are not favorable as described in Section 4.1. Yet, the blood is 
perishable and needs to be in a testing center/storage within 24 hrs after donation. 
Therefore, using a variant of Selective VRP will not be sufficient. Doerner and Hartl 
[19], [20] suggests collecting blood from the bloodmobiles in the field with the help of a 
collector vehicle where they take the locations of bloodmobiles as fixed points. 
However, we need to develop a whole bloodmobile system for TRC and tours of blood 
locations need to be decided as well. As a result, we will adopt a selective VRP 
approach and combine it with the collector vehicle idea where the bloodmobiles perform 
Selective VRP tours and the shuttle's (collector vehicle) tours will be determined by the 
stops of blood mobiles by the developed model as described in the next section. 
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Chapter 5  
 
Model Development 
Although TRC owns bloodmobiles, it does not systematically perform blood collection 
via bloodmobiles. In order to develop a good and operable system for TRC we adopt 
some useful ideas from literature and develop a complete mobile blood collection 
system. In the proposed system bloodmobiles perform regular tours to points with blood 
potential. Also, the new system will utilize a single shuttle for each Blood Center or 
Regional Blood Center. This shuttle collects the blood from the bloodmobiles in the 
field that are assigned to that particular BC/RBC. Thus, this problem is to be solved for 
each BC/RBC in isolation at the beginning of each week.  
5.1 IP Models 
The proposed mobile blood collection system entails a complex problem with several 
considerations. First of all, the problem has two major objectives: achieving high blood 
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collection amounts and keeping logistics costs low. Also, the decision maker needs to 
select the nodes to be visited, the duration of the visits and the routes of the 
bloodmobiles and the shuttle among the selected nodes. We model the decision maker's 
problem as a Selective Vehicle Routing Problem with Integrated Tours. Considerations 
that are taken into account within this problem are as follows: 
1. Each tour starts and ends at an RBC/BC which will be referred as depot here on. 
2. Bloodmobiles may visit a proper subset of the nodes. 
3.  A bloodmobile can visit any given node at most for once. The stay-over period 
of a bloodmobile at a given node is restricted between 1 – 3 days. 
4. If a bloodmobile visits a node, it should stay at that node for at least one day.  
5. The blood collected at a node should be transferred to the depot in the evening 
either by the shuttle or the bloodmobile itself on its return at the end of its tour. 
Let G= (N, A) be a geographical network, where N is the set of potential stops of the 
bloodmobile and the depot. Set A represents the roads between these nodes. In order to 
model the possible stay-overs of bloodmobiles, we will use an extended version of G. 
Let G' be the extended version of the geographical network for modeling the stay-overs 
on nodes. For each actual potential location, G' has three nodes, the first one is the 
original node (v) and the other two are the artificial nodes (v') and ( v'') corresponding to 
two-day and three-day stay-overs, respectively. The model takes into account stay over 
periods of up to three days. If the solution reveals that a blood mobile visits v' (v''), it 
means the bloodmobile stays in v for 2 (3) days. G is designed in a way that v' (v'') 
cannot be visited unless a bloodmobile visits v (v'). With this set-up, an original node (v) 
is accessible from an artificial node, but an artificial node can be reached only from its 
original node. 
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Formally, G' = (N', A'), where |N'| = 3|N| and	||, || represents 2 and 3 day stay-
overs respectively ∀	 	 ∈ 
.  Let  represents the arc distance between node i and 
node j in G. In G', the arc distances are defined as follows: 
′ =			, ∀ ≡ 	||, ∀ ≡ 	||									(∗)		 
As a result, ,|| =	,|| = 0, since  = 0	∀ ∈ 
. Despite the stay overs are 
described as separate nodes, the travel between an actual node and the copy node has 0 
cost with the help of this cost function. 
The blood potentials of the artificial nodes are also defined as a function. The past blood 
collection activities of TRC shows that the blood potential of a node in the second or 
third day of the activity is less than the first day. In order to model this behavior we 
develop a decreasing function that represents the blood potentials for artificial nodes. Let  , be the blood potential of an original node  ∈ 
 on the first day of visit. Then, the 
blood potential of a node  ∈ 
 is defined as follows: 
 =	 ,																										 	 ≤ |
|",									 	|
| <  ≤ 2|
|",																			 	 > 2|
|&                 (**) 
β is a parameter that belongs to [0,1] interval, so that this function can model the 
decrease of blood potential during the stay-over period. The estimation process of β will 
be described in Chapter 6. Also, a detailed sensitivity analysis on the value of β is 
conducted in that chapter. 
Let D represent the days in the planning horizon of the problem and consider m identical 
bloodmobiles. The output model will be m tours for the bloodmobiles and up to |D| - 1 
tours for the shuttle. The tours of the bloodmobiles start on the first day and end at or 
before end of the planning horizon. On the other hand, each tour of a shuttle starts and 
ends on the same day. Since the bloodmobiles transfer the collected blood themselves on 
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their return to the depot; the shuttle does not need to work on the last day of their 
respective tours. Incidentally, as all bloodmobiles will have returned to the depot by the 
end of the planning horizon the shuttles do not need to be in service on this last day.  
Problem parameters are defined as follows: 
′ = 'ℎ)	*+,)--./	0*	 +	.)		,.	*	.)	, 1ℎ)+)	(, ) ∈ 2′  
	 = 'ℎ)	-	3*).*,-	 	.)	, 1ℎ)+)	 ∈ 
′ 
4 = 5)0+)	,-6)	 +	*ℎ)	,6.*	 	-	*	)	--)*) 
 = 
6)+	 	--)0 
Decision variables are defined as follows: 
78 = 91,  	,	--)	*+,)-0	*	.)	 ∈ 
+)*-;	 +	.)		 ∈ 
 ′	.	,;	 ∈ 5						0, 1																																																																																																																																																															& 
;8 = 91,  	*ℎ)	0ℎ6**-)	*+,)-0	*	.)		 ∈ 
 ′	+)*-;	 +	.)		 ∈ 
 ′.	,;	 ∈ 5						0, 1																																																																																																																																																									& 
<8 = 91,  	.)		 ∈ 
 ′	+)=6+)0	,	0ℎ6**-)	.	,;	 ∈ 5																																																								0, 1																																																																																																																																															 & 
> = 6;	.*.660	,+,-)	*ℎ,*	+)3+)0).*0	*ℎ)	+)+	 	.)	 ∈ 
	.	,	0ℎ6**-)	*6+ 
The proposed model (MinCost-B*-Blood) is as follows:  
.<) ? ?′ ?@8	8∈A∈′∈′ + ? ?′ ?C8 	8∈A∈′∈′ 																																														(D1) 
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subject	to	
			? @8∈′ = M8 + @N8N, ∀ ∈ O2, … ,
Q, ∀ ∈ O1,… , 5 − 1Q (1)  
? (@N8N +	M88∈ON,…,ASNQ ) 	≤ 1, ∀ ∈ O2,… ,
Q (2)  
			? @8∈′ =	? @T8NT∈′ , ∀ ∈ O2, … , 
Q, ∀ ∈ O1,… , 5 − 1Q (3)  
			? @NN∈′ = 	 (4)  
			? ? @N∈O,…,′Q∈′ = 0 (5)  
				? ?@N88∈A∈′ = 	 (6)  
				? ?@N88∈A∈′ = 	 (7)  
				? @8∈′ ≥ @(||8N, ∀ ∈ O1, … ,2|
|Q, ∀ ∈ O1,… , 5 − 1Q	 (8)  
					@S8 	≥ M8 + @N8N, ∀ ∈ O|
| + 1,… 3|
|Q, ∀ ∈ O1,… , 5 − 1Q (9)  
				? C8
∈′
=	M8 , ∀ ∈ 
, ∀ ∈ O1,… , 5 − 1Q (10) 
				? CW8
∈′
=	M8 , ∀ ∈ 
, ∀ ∈ O1,… , 5 − 1Q (11) 
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? M8
∈O,…,Q
≤  ? CN8
∈O,…,Q
, ∀ ∈ O1, … , 5 − 1Q (12) 
? M8
∈O,…,Q
≤  ? CN8
∈O,…,Q
, ∀ ∈ O1,… , 5 − 1Q (13) 
			> −	> + 	C8 		≤  − 1, ∀ ∈ O2,… ,
′Q, ∀ ∈ O1,… ,
′Q, ∀ ∈ O1,… , 5Q (14) 
			> ≥ 0, ∀ ∈ O2, … , 
′Q,							 (15) 
			? 
∈′
??@8
8∈A∈′
≥ 4∗ (16) 
   @8, C8,M8  ∈  O0,1Q    ∀ ∈ O1, … , 5Q, ∀ ∈ O1, … , 
′Q, ∀ ∈ O1, … , 
′Q (17) 
 
Constraint set (1) ensures that if a bloodmobile visits node j on day d, then node j should 
either be visited by the shuttle also on day d or the bloodmobile returns directly to the 
depot immediately after node j on day d+1. Constraint set (2) restricts a node to be 
visited at most once. Constraint set (3) specifies the flow balance conditions such that if 
there is a bloodmobile coming to node j on day d there should be also an outgoing one 
from node j on day d+1. Constraint (4) forces all bloodmobile tours to start on day 1. 
Constraint (5) prevents tours starting from any node other than the depot. Constraints (6) 
restrict the number of vehicles leaving the depot. Constraint (7) ensures all bloodmobiles 
turn to the depot. Both constraints (6) and (7) allow self tours for depot. Therefore, if a 
bloodmobile is not needed, then a self tour of depot is used. Constraint set (8) satisfies 
that if a node is visited for longer than one day, the bloodmobile should stay on that 
node consecutively. Constraint set (9) forces that if an expanded node (j+|N|) is visited 
on day d+1, then the original node j should have been visited on day d.  Constraint sets 
(10) and (11) ensure that the shuttle picks up the collected blood from the nodes that are 
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require shuttle service. Constraint sets (12) and (13) initiate and finalize shuttle tours 
even if there is a single node requiring the shuttle service on day d. Constraint sets (14) - 
(15) represent Miller- Tucker- Zemlin (MTZ) sub-tour elimination constraints for shuttle 
tours. Constraint set (16) ensures blood-collectors to achieve a desired blood level B* 
that is determined by the decision maker. Finally, constraint set (17) is integrality 
definition of the decision variables. The model contains MTZ constraints for only shuttle 
tours. Since, for each day a shuttle tour is performed, these constraints together with the 
constraint set (3) also prevents subtours in bloodmobiles. 
The desired blood level B could be determined by considering the current inventory 
levels or the decision maker may consider the collected blood amount as a second 
objective. Hence, we also need to find the maximum amount of blood for a given district 
while respecting the system constraints such as the number of vehicles and tour lengths 
in days.  One way of doing this is simply moving the LHS of constraint set 16 to the 
objective function and solving MinCost-B*-Blood as a maximization problem but, this 
model considers the shuttle tours as well. Obviously, the shuttle tours do not affect the 
amount of blood collected by bloodmobiles. Because of this reason, MinCost-B*-Blood 
has redundancies such as the shuttle tours and their connection with the bloodmobile 
tours. Since the maximum amount of blood that can be collected from a given instance is 
not determined by the shuttles, a smaller IP which focuses only on the blood-collector-
vehicles is developed.   
Constraints (10) - (15) in MinCost-B*-Blood build shuttle tours, so our new model will 
not include them. In addition to that, variable M8connects the collector tours to the 
shuttle tours via constraint (1) so we can eliminate these variables in our new model. We 
can replace M8 	with ∑ @8YZN − @N8N by constraint (1) in the constraint sets (2) 
and (9). With these substitutions we obtain constraint sets (18) and (19) instead of (2) 
and (9) respectively: 
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? ? @8
8∈ON,…,|A|SNQ∈′
≤ 	1, ∀ ∈ O2,… ,
′Q (18)
@S8 	≥ ?@T8N
Y
TZN
, ∀ ∈ O|
| + 1,… 3|
|Q, ∀ ∈ O1, … , 5 − 1Q (19)
The projected model (MaxBlood) is as follows:  
,7<)?  ? ? @8
8∈ON,…,|A|SNQ∈′∈′
																																																																												D2 
06)*	*  
(3),(4),(5),(6),(7),(8),(17),(18),(19) 
[ −	[ +	 |5|@8 		≤ |5| − 1,			∀ ∈ O1,… , 5Q, ∀ ∈ O2,… , 
′Q, ∀ ∈ O2, … , 
′Q (20) 
[ ≥ 0,			∀ ∈ O2, … , 
′Q																																									 (21) 
 
Recall that sub-tours of blood collectors are prevented by the shuttle sub-tour 
elimination constraints in the previous model. Since those constraints are not included in 
the second model, we add Miller-Tucker-Zemlin constraints (20)-(21) for blood 
collectors.   
After the maximum amount of blood that can be collected is determined by MaxBlood, 
that amount can be given to MinCost-B*-Blood as an aspiration level as B and the model 
is solved with the objective of minimizing the total cost. Obviously, there exists a 
feasible collector and shuttle tour that can obtain the blood amount that is found in 
MaxBlood, since there are no distance limitations on the shuttle tours. 
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5.2 Valid Inequalities 
A set of logical valid inequalities are developed to improve the performance of MinCost-
B*-Blood. First of all, since we know that any artificial nodes cannot be visited before 
the corresponding original node, we know that on the very first day of the planning 
horizon no artificial nodes will be visited by a bloodmobile. Therefore, the shuttle will 
not visit any artificial node on the first day, either. Since, this information is known a 
priori, it can also be considered as a pre-processing operation. This argument yields the 
valid inequality 1:  
? <N = 0								
∈O||N,…,Y||Q
 
(22)
Secondly, we design our constraints so that, a two day stay over node is accessible only 
from its original node and a three day stay over node is accessible from its two day stay 
over node. Thus, the flow of the bloodmobile is in this forward direction and no flow is 
allowed in the backward direction. For this reason, we know that any artificial node 
succeeds a three-day stay-over node on a blood mobile tour. The mathematical 
expression for this valid inequality 2 is as follows: 
? ? 78 = 0,				∀ ∈ O2|
| + 1,… ,3|
|Q			
∈O||N,…,Y||Q8∈ON,..,ASNQ
 
(23)
Finally, we know that if a bloodmobile returns to the depot before the end of the 
planning horizon, we will have one less bloodmobile in the field than the previous day. 
Of course, it is not true for the last day of the planning horizon, so we rule out the last 
day. We can express this statement as a valid inequality as follows: 
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? @N8
∈O,…′Q
=	? ?@8 −
∈′∈′
? ?@8N
∈′∈′
, ∀ ∈ O1,… , |5| − 1Q (24)
The next chapter will present the computational results on the performances of MinCost-
B*-Blood and MaxBlood as well as the combinations of the valid inequalities described 
above. Also, the results of the sensitivity analysis on the problem parameters can be 
found in Chapter 6.   
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Chapter 6  
 
Computational Analysis 
In order to test the performance of developed methodologies and obtain theoretical and 
managerial insights, a series of experiments are conducted on several data sets. In this 
chapter, data sets and results of experiments will be explained in detail. 
6.1. Data Sets 
In this study, computational experiments are based on two different data sets. This 
problem is inspired by the bloodmobile collection problem of TRC Ankara. Therefore, 
real donation data of past blood collection activities in Ankara is gathered. Secondly, 
GIS data belonging to the districts in the European Part of Istanbul is collected and each 
district is considered as a potential point while the blood potential is assumed to be 
proportional with the population of districts. 
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Headquarters of TRC in Ankara has blood collection activity data of the past years 
containing the date, location and the collected amount of blood. TRC supplied the blood 
collection data that is obtained in 2009-2010. Since0 TRC keeps track of every donation 
activity; it is not realistic to use all of this information. Some of the activities can be a 
one-time donation campaign, while some others may be traditional ones that repeat after 
a certain time interval. For instance, some companies or colleges have an annual 
donation campaigns whereas some other companies decide to improve their image and 
organize a blood donation activity. After a series of meetings, these cases are eliminated 
and we focus on the activities that may repeat and so can be considered as a potential 
stop of bloodmobiles. In addition to that, some of the points closer than 1 km are  
aggregated. After these eliminations, we end up with 38 potential points in Ankara with 
known blood potentials. TRC’s headquarter in Kızılay is the ultimate stop of current 
blood mobiles, which is also a RBC that serves Middle Anatolian Region of Turkey. For 
this reason, we consider that building as the depot in our analysis. These 38 points and 
the depot are pinned in Figure 6.1. 
 
Figure 6-1 Potential points of Ankara(Yellow point represents the depot) 
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After deciding the potential points in Ankara, we constructed the distance matrix 
between these points. Instead of Euclidean distances, using actual road distances yields 
more realistic solutions. For this construction, we use TomTom Online Route Planner 
(http://routes.tomtom.com/) with the shortest route option. Utilization of TomTom Route 
Planner gives us the actual road distances between the points under consideration. The 
selected points, their blood potentials and the original distance matrix can be seen in 
Appendix 1.   
Unlike Ankara, Istanbul data is not based on past activities, but instead is considered as 
an a priori analysis for future blood collection activities. For this reason, all the districts 
in the European part of Istanbul have been taken into account. Again, closer districts and 
their populations are aggregated and the actual center of TRC in Fatih, which is a BC, is 
considered as depot. After this aggregation, 97 points including depot. These 96 district 
centers and the depot are pinned in Figure 6.2. 
 
Figure 6-2 Potential points of Istanbul (Red point represents the depot) 
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After this aggregation, the distances between these districts are calculated via 
Geographical Information System software as an approximation of the actual road 
distances. Also, the populations are considered as the blood potentials of the districts.  
As it is described in Chapter 5, the maximum length of a visit by a bloodmobile is 
determined as three days. We triplicate the original cost matrix with the cost function (*) 
as described in Chapter 5. At the end of this process, we have three new nodes for each 
original node. For node i in the original matrix, node i ,i + |N|, i +2|N| corresponds to 
original node, 2-day-stay-over node and 3-day-stay-over node respectively. Also, we 
need to define the blood potentials of these artificial nodes. We assume that, blood 
potential decreases as the bloodmobile continues to stay in a given node, with a pre-
determined coefficient β. If a node’s original blood potential is	, then second day’s and 
third day’s potentials are   ∗ 	" and	 ∗ 	", respectively (**). In our calculations, we 
estimated the value of β as 0.8. We consider our planning horizon as seven days. We 
know that TRC Ankara has three bloodmobiles, and we conduct our experiments 
accordingly. Finally, all these computations are performed on an Intel Core i7 2.20GHz 
PC with 8 GB RAM. Gurobi version 5.0.0 is used to solve these models.  
6.2. Base Case Analysis for Ankara and Istanbul Instances 
With the data sets described in previous section we test the proposed system for Ankara 
and Istanbul cases and compare results with the current system. For both instances, we 
first solve the MaxBlood to calculate the maximum amount of blood that can be obtained 
in 7 days with 3 vehicles. After that, we feed the optimal solution of MaxBlood to 
MinCost-B*-Blood, as B* in constraint (15) to minimize the total logistics costs of 
collecting that amount. 
Firstly, we focus on the Ankara instance since it is constructed based on real blood 
collection data. The optimal solutions and CPU times can be seen in Table 6.1. 
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Table 6-1 MaxBlood and MinCost-B*-Blood results for Ankara 
 
objective cpu node iteration shuttle dist 
bloodmobile 
dist 
MaxBlood  1420(units) 34 sec 0 27852 
  
MinCost- 
B
*
-Blood 
912.5 (km) 212 sec 410 63266 456.6 (km) 455.9 (km) 
From 38 candidate stops the bloodmobiles choose to visit only 11 of them. At the end of 
the planning horizon bloodmobiles collect 1420 units of blood and traverse 912.5 km.s. 
If these points were visited with dedicated tours, as it is in the current system, the total 
distance travelled would be 1011 km.s. Thus, for Ankara case, it can be claimed that the 
proposed system performs better than the current system. The overall tours of 
bloodmobiles and the shuttle tours in different days are as in the Appendix 2. 
Secondly, Istanbul case is analyzed for a future possible implementation. After an 
approximation of Istanbul network is constructed, we solve MaxBlood and MinCost-B*-
Blood for this instance as well. The results for 3 vehicles and 7 days are given in Table 
6.2. 
Table 6-2 MaxBlood and MinCost-B*-Blood results for Istanbul 
 
objective cpu node iteration shuttle dist 
bloodmobile 
dist 
MaxBlood 9004079(people) 207 sec 0 62551 
  
MinCost- 
B
*
-Blood 
446.613(km) 2083 sec 2228 138757 304.096(km) 142.517(km) 
The bloodmobiles visit 9 of 96 candidate stops and reach 9004079 people whereas the 
vehicles travel for approximately 446 km.s. If bloodmobiles performed dedicated tours 
to visit these selected nodes, the total distance would be 661.6 km.s. Therefore, the 
proposed system yields a better solution for Istanbul case as well. The bloodmobile and 
shuttle tours for Istanbul instance are given in Appendix 3.  
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6.3 Depot Location Analysis 
In order to further test the performance of the proposed models new instances are 
generated out of the original Ankara network as well. Random subsets with size 35, 30 
and 25 (5 instances for each) are chosen, then MaxBlood and MinCost-B*-Blood solved 
on these instances. At first, these instances considered with the original depot but then, 
also for each instance, another random node is chosen as the depot. The objectives, 
solution times, and the proportion of the bloodmobile and the shuttle in the cost can be 
seen in Table 6.3. The instances in the left hand side are the original instances. The 
instances in the right hand side solved for the corresponding LHS instances with a 
random depot selection. The reason for performing such an analysis is to observe the 
effect of the depot location on solution times. There are different studies in the literature 
that conclude solving a VRP problem with a central depot is easier than one with an off-
the-center depot instance. The locations of depots of corresponding random instances are 
shown in Appendix 4. 
Contrary to the commonsense, smaller instances may require more time than larger ones 
on the average. Average time to solve the instances with 25 nodes is 99.4 seconds 
whereas the average for the instances with 30 nodes is 196.6.  
Also, it can be seen from the table that when the depot is central, the bloodmobile and 
shuttle proportions of the total cost is comparable. On the other hand, the shuttle costs 
almost always (in all cases except for instance 28) outweigh the bloodmobile costs when 
the depot is chosen randomly, so that may not be central. The reason is that, the nodes 
with high potentials are chosen as definite stops, but this time, their distribution around 
the depot may not be homogenous. Since the shuttle performs daily tours between these 
distant points, the tour lengths of it increase. Also, it can be deduced from this table that 
solving the instances with random depot locations requires longer solution times. Again, 
it can be seen that CPU times of the instances in the right hand side are almost always 
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longer (in all cases except for instances 28 and 30). Yet, these findings cannot be 
generalized and the performances of the models highly depend on the instances. 
Table 6-3 Generated instance results of Ankara 
  actual depot random depot 
Size 
 
ins MinCost- 
B
*
-Blood 
shuttle 
(%) 
b.mobile 
(%) 
cpu 
(sec) 
ins MinCost- 
B
*
-Blood 
shuttle 
(%) 
b.mobile 
(%) 
cpu 
(sec) 
3
5
x
3
5
 
ins 1 912.5 50.04 49.96 130 ins16 931.2 54.07 45.93 164 
ins 2 912.5 50.04 49.96 141 ins17 1341.5 54.95 45.05 1764 
ins 3 792.1 42.84 57.16 119 ins18 1095.1 55.79 44.21 8245 
ins 4 912.5 50.04 49.96 131 ins19 1017.8 53.53 46.47 824 
ins 5 972 54.66 45.34 121 ins20 1004 55.29 44.71 362 
    AVG 128.4    AVG 2227.1 
3
0
x
3
0
 
ins 6 1151.8 53.13 46.87 118 ins21 1056.5 55.95 44.05 219 
ins 7 1021 56.64 43.36 78 ins22 2120.4 59.55 40.45 300 
ins 8 538.3 48.58 51.42 98 ins23 632.5 52.71 47.29 2056 
ins 9 858.2 61.83 38.17 82 ins24 863.2 62.01 37.99 142 
ins 10 893.4 53.35 46.65 121 ins25 912.1 53.45 46.55 242 
    AVG 99.4    AVG 591.8 
2
5
x
2
5
 
ins 11 1015.9 55.72 44.28 57 ins26 1023.8 56.47 43.53 110 
ins 12 929.6 46.07 53.93 105 ins27 1071 50.85 49.15 203 
ins 13 1075.8 45.97 54.03 332 ins28 1094.5 44.98 55.02 245 
ins 14 980.3 50.67 49.33 204 ins29 993 51.03 48.97 232 
ins 15 1137.6 51.36 48.64 285 ins30 1147.8 51.71 48.29 149 
   AVG 196.6    AVG 187.8 
           
It can be stated that the location of the depot affects both the total logistics costs and the 
solution times significantly. This observation yields us another analysis on the depot 
locations of Ankara and Istanbul. The current locations of each depot might be chosen 
according to the population density and traffic load. However, there may be better 
alternatives that may yield decreased logistics costs. As a first alternative, for each point, 
we calculate the maximum distance to another point, say ,7 , and then we choose the 
point with the minimum ,7 value as depot. We also calculate the weighted distances 
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for each point, and choose the one with the lowest value as the depot. For this 
calculation, the blood potentials (populations) are used as weights. For computational 
comparison purposes we also, choose a random depot location as another instance. The 
results of these settings for Ankara and Istanbul cases, the objective values and 
computational statistics can be seen in Tables 6.4. and 6.5, respectively. 
Table 6-4 Depot location analysis results of Ankara 
Ankara obj(km) cpu (sec) node itn ct shuttle(km) b.mobile(km) 
actual ctr 912.5 212 410 63266 456.6 455.9 
random ctr 1037.6 237 2838 145212 640.5 397.1 
maxmin ctr 930.9 245 897 69520 474.9 456 
weighted ctr 907.1 151 363 42372 465.7 441.4 
 
Table 6-5 Depot location analysis results of Istanbul 
Istanbul obj (km) cpu (sec) node itn ct shuttle(km) b.mobile(km) 
actual ctr 446613 2083 2228 138757 304096 142517 
random ctr 577611 3606 13537 793421 380835 196776 
maxmin ctr 899509 5632 68625 3951977 598773 300736 
weighted ctr 391779 3234 1613 101761 272183 119596 
The best alternatives with respect to the logistics cost are marked in both tables. 
Expectedly, the best logistics cost for both Ankara and Istanbul are provided by the 
depot location that is closest to the center of mass of the network. Since, these selections 
are as close as possible to the points with high blood potentials these results are 
expected. Also, these results show that the current locations of depots are really chosen 
well because the objective values between the actual center and weighted center cases 
are not very high. The maxmin center of Istanbul performs even worse than a random 
selection of depot location because the population of the European side in Istanbul is 
very dense in the districts that are closer to the Bosphorus. As a result, solely focusing 
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on the distances and neglecting the population may result in poor objective values. We 
also observe that the shuttle tours dominate the bloodmobiles tours.  
With this analysis, we compare several depot location alternatives, in two very different 
metropolitan structures of Ankara and Istanbul. Ankara has a circular structure around a 
single geographical city center, and its population is more or less homogenously 
distributed. On the other hand, the geographical center and the population-center of the 
European side of the Istanbul are far from each other. The population is accumulated 
along the Bosphorus shore, which is almost at the boundary of the region. However, the 
weighted center performs very well in both instances. Yet, it can be suggested that an 
analysis on the metropolitan structure of the city under consideration must be conducted 
while deciding on the location of  the depot. 
6.4 Valid Inequalities 
The performance of valid inequalities that are defined in Chapter 5 are tested with 
different depot alternatives in order to eliminate the effect of depot location. All three 
valid inequalities are added both individually and in all possible combinations to 
MinCost-B*-Blood to solve the Ankara (39 nodes) and Istanbul (97 nodes) instances with 
the actual,  random and min-max depot locations. The results are given in Table 6.6 for 
Ankara and in Table 6.7 for Istanbul. 
. 
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Table 6-6 Valid inequality performances of Ankara instances with different depot 
locations 
Ankara(39x39) cpu(sec) node itn ct  cpu(sec) node itn ct 
actual  center 
   
maxmin 
center 
   
MinCost- 
B
*
-Blood 
212  410 63266 
MinCost-
B
*
-Blood 
245 sec 897 69520 
VI 1 174  361 53721 VI 1 209 sec 422 55972 
VI 2 227  1074 77451 VI 2 202 sec 1247 65944 
VI 3 217  532 63291 VI 3 247 sec 760 66329 
VI 1 & VI 2 184  393 64705 VI 1 &VI 2 192 sec 159 42585 
VI 1 & VI 3 186  433 63271 VI 1 &VI 3 176 sec 266 47414 
VI 2 & VI 3 182  705 66720 VI 2 & VI 3 231 sec 1214 76065 
VI 1 & VI 2 & 
VI 3 
186  1082 88551 
VI 1 &VI 2 
& VI 3 
197 sec 634 49953 
    
    
random center 
   
weighted 
center 
   
MinCost-B
*
-
Blood 
237  2838 145212 
MinCost-
B
*
-Blood 
151  363 42372 
VI 1 232  2567 134985 VI 1 218  315 44524 
VI 2 380  4807 240119 VI 2 142  439 45073 
VI 3 335  3358 173624 VI 3 212 613 66943 
VI 1 & VI 2 415  4538 254072 VI 1 & VI 2 183 555 53638 
VI 1 & VI 3 272  2445 136882 VI 1 & VI 3 194 878 62123 
VI 2 & VI 3 373  5113 313165 VI 2 & VI 3 189 778 61446 
VI 1 & VI 2 & 
VI 3 
360  3482 200249 
VI 1 & VI 2 
& VI 3 
227  331 54891 
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Table 6-7 Valid inequality performances of Istanbul case with different depot locations 
Istanbul 
(97x97) 
cpu node itn ct 
 
cpu node itn ct 
actual  center 
   
maxmin 
center 
   
MinCost-B
*
-
Blood 
2083 
sec 
2228 138757 
MinCost-
B
*
-Blood 
5632 
sec 
68625 3951977 
VI 1 
3180 
sec 
1407 115689 VI 1 
5270 
sec 
109666 4022727 
VI 2 
2062 
sec 
2097 134682 VI 2 
6898 
sec 
197546 6980756 
VI 3 
2968 
sec 
1528 119483 VI 3 
6246 
sec 
130692 5166434 
VI 1 & VI 2 
4648 
sec 
3223 190774 VI 1 & VI 2 
6500 
sec 
143740 4984827 
VI 1 & VI 3 
3733 
sec 
5250 397130 VI 1 & VI 3 
4137 
sec 
70392 3376800 
VI 2 & VI 3 
2277 
sec 
2982 145964 VI 2 & VI 3 
3898 
sec 
63700 2466664 
VI 1 & VI 2 & 
VI 3 
2330 
sec 
1582 118492 
VI 1 & VI 2 
& VI 3 
3783 
sec 
71999 3895625 
    
    
random center 
   
weighted 
center 
   
MinCost-B
*
-
Blood 
3606 
sec 
13537 793421 
MinCost-
B
*
-Blood 
3234 
sec 
1613 101761 
VI 1 
3943 
sec 
17673 991983 VI 1 
3357 
sec 
1663 125626 
VI 2 
3325 
sec 
8962 532142 VI 2 
2784 
sec 
1970 151242 
VI 3 
5087 
sec 
15954 941116 VI 3 
2875 
sec 
1959 142023 
VI 1 & VI 2 
6196 
sec 
10763 522922 VI 1 & VI 2 
4260 
sec 
4966 288313 
VI 1 & VI 3 
5704 
sec 
11715 604073 VI 1 & VI 3 
2507 
sec 
1848 139581 
VI 2 & VI 3 
7188 
sec 
24549 1364994 VI 2 & VI 3 
5244 
sec 
3498 261758 
VI 1 & VI 2 & 
VI 3 
4735 
sec 
9530 510820 
VI 1 & VI 2 
& VI 3 
3389 
sec 
2255 137153 
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VI 1, VI 2, VI 3 corresponds to the inequality sets (22), (23), (24) that are defined in 
Chapter 5, respectively. Valid inequality combinations with the best computational times 
are underlined for all data sets. As it can be seen from these tables, valid inequalities do 
not perform consistently in terms of computational times. However, in all six instances 
there exists at least one inequality combination that outperforms the original IP. 
Therefore, we use all three inequalities in our further analysis.  
6.5 Pareto Optimum Analysis of the Original Ankara and Istanbul 
Cases  
Our problem is based on two different objectives: maximizing the amount of collected 
blood and minimizing the logistics cost of collection. Therefore, the interaction between 
these two objectives is  of interest. Also, such an analysis allows the decision makers in 
TRC to perform a posteriori deductions. For this reason, the efficient frontier of these 
two objectives is generated for both the Ankara and Istanbul instances.  
For the Ankara case, we decrease the percentage of blood collected with increments of 
10, where 100 percent corresponds the objective of MaxBlood. The we solve MinCost-
B*-Blood with corresponding blood levels. For Istanbul, we manage to obtain some of 
the points on the efficient frontier. However, problems corresponding to some of the 
points were not possible to solve with this methodology. For this reason, we switched 
constraint 16 and the objective function, so that the model finds the best possible amount 
of blood with a given level of logistics cost. In both cases, one extremum is defined by 
the original solution of the problem (cost of collecting maximum amount of blood) and 
the second one is basically set to zero units of blood and zero cost. Figures 6.3 and 6.4 
represent the efficient frontiers of Ankara and Istanbul instances, respectively. 
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Figure 6-3 Pareto Optimum Curve of Ankara Case 
 
Figure 6-4 Pareto Optimum Curve of Istanbul Case 
These two figures show that, if TRC settles for 10% less of the maximum possible 
blood, they save on logistics costs significantly. The decrease in Ankara case is steeper 
than the Istanbul case, which can be explained by the location of the depot and the more 
intense distribution of high blood potential nodes around the depot.  
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6.6 Sensitivity Analysis on Problem Parameters 
Finally, we conduct a sensitivity analysis on two parameters of our problem, which are 
the number vehicles and the constant β. TRC Ankara has three bloodmobiles currently. 
Thus, the analysis is conducted for number of 2, 3, 4 and 5 bloodmobiles. The blood 
constant β, is determined empirically. Thus, in order to model different donor behaviors 
or reducing estimation biases, we also change the value of β between 0 and 1 in 
increments of 0.2. By changing, these values we observe the trends on the objectives as 
well as the number of nodes that are visited for longer than one day. In Table 6.8, the 
objective function values, number of nodes with 'long' visits and computational times are 
summarized. The table also shows the percentage marginal increment in both objectives 
with the change of problem parameters. 
Both objectives increase when the number of vehicles increases or when β increases. 
This is an expected result. On the other hand, the marginal increments of blood are not 
as large as the cost increments. In other words, the increase in cost is much higher than 
that in blood. These statistics show that introducing a new bloodmobile to the system 
may not be easily justified. In particular, when the distance traversed per blood unit 
(shown in the rightmost column) is considered, 5 vehicles are not justified for β values 
of 0.2, 0.6, 0.8 and 1 and also in almost all cases 3 vehicles yield very efficient results.  
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Table 6-8 Sensitivity Analysis Results on Problem Parameters 
alpha # veh MaxBlood 
marg. 
Inc(%) 
MinCost 
marg. 
Inc(%) 
# 
nodes 
stayed 
in 2 
days 
# 
nodes 
stayed 
in 3 
days 
CPU of 
MinCost 
in 
sec(gap 
%) 
dist/ 
blood 
0.2 
2 871 0.00 775.6 0.00 0 0 347 0.89 
3 1114 27.90 1138.7 46.82 1 0 2127 1.02 
4 1289 47.99 1320 70.19 1 0 
36000  
(5.86%) 
1.02 
5 1419 62.92 1663.6 114.49 2 0 
36000  
(21.32%) 
1.17 
0.4 
2 905 0.00 745 0.00 1 0 300 0.82 
3 1151 27.18 1138.7 52.85 1 0 2436 0.99 
4 1348 48.95 1355.7 81.97 3 1 
36000  
(4.39%) 
1.01 
5 1509 66.74 1399.7 87.88 5 1 
36000  
(6.92%) 
0.93 
0.6 
2 976 0.00 804.1 0.00 1 1 183 0.82 
3 1253 28.38 855.8 6.43 3 1 894 0.68 
4 1483 51.95 1220.5 51.78 6 1 7947 0.82 
5 1679 72.03 1551.1 92.90 8 3 16711 0.92 
0.8 
2 1107 0.00 658.2 0.00 2 2 199 0.59 
3 1420 28.27 912.5 38.64 2 4 136 0.64 
4 1698 53.39 1056.1 60.45 3 5 1091 0.62 
5 1945 75.70 1508.5 129.19 4 7 8545 0.78 
1 
2 1316 0.00 556.1 0.00 0 4 60 0.42 
3 1690 28.42 714.8 28.54 0 6 132 0.42 
4 2025 53.88 1152.5 107.25 0 8 335 0.57 
5 2322 76.44 1209.4 117.48 0 10 503 0.52 
 
When the β value is 1, the bloodmobiles always choose to perform 3-day stay overs 
when applicable since the blood potential of a node never decreases during a visit. As a 
result, the nodes with high potentials are visited until the end of the permissible stay-
over length, which is 3 days in our calculations. As the β value decreases, the length of 
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the visits gets shorter because visiting a new node becomes more advantageous than 
waiting in the current node in terms of the available blood potential . When the β value 
reaches 0.2, bloodmobiles do not wait at any of the nodes for three days. This situation 
may also explain the long computational times of instances with lower than β values. 
The problem becomes more difficult to solve when most of the stay over options offer 
comparable blood potentials with other unvisited nodes, as β decreases. The change in 
the number of nodes that are visited for 2 and 3 days are represented in Figure 6-5, 6-6, 
6-7  and 6-8 for number of vehicles two, three, four, and five respectively. 
 
Figure 6-5 Number of nodes visited for 2 and 3 days with number of b.mobiles 2 
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Figure 6-6 Number of nodes visited for 2 and 3 days with number of b.mobiles 3 
 
Figure 6-7 Number of nodes visited for 2 and 3 days with number of b.mobiles 4 
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Figure 6-8 Number of nodes visited for 2 and 3 days with number of b.mobiles 5 
The stay-over behavior when β increases, is independent of the number of vehicles. In 
all three alternatives of vehicle count, the number of nodes that are visited for 2 days 
first increases, and then then drops to 0. Similarly, 3 day stay overs start with 0 and 
increases until β reaches to 1, for the cases with 2, 3, 4 and 5 vehicles. 
To sum up, both the number of bloodmobiles and the β value have significant effects on 
the objectives. However, increasing the bloodmobiles may not always increase the 
efficiency of the system as explained before. On the other hand, if β can be controlled, 
the amount of blood collected can significantly increase. To maintain a higher β value 
may not be as difficult as it seems. Increasing public's attention to the activity may yield 
high blood potentials on the second, even the third day of activity. The tours need to be 
determined long before the collection activity to leave enough time for the 
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announcement of the activity. The target population should be informed about the 
starting date and the length of the collection activity beforehand, so that they can arrange 
their schedules accordingly.   
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Chapter 7  
 
2 Stage IP-based Heuristic Algorithm 
Since our problem is defined on a time expanded network and it contains typical VRP-
TSP constraints, as the number of potential points or the stay-over period grows, the 
underlying network gets larger. Especially, the stay-over period markedly affects the 
number of nodes in the network. Hence, for such instances (with long stay-over periods 
or many potential points) computational time may be significantly long. This is not a 
desirable case for decision makers in TRC, since the proposed planning period is 7 days.  
With these considerations in mind, we design a 2-stage IP based heuristic approach 
which yields shorter computational time to obtain good solutions with small optimality 
gaps.  
The proposed heuristic can be summarized in three steps as follows: 
66 
 
1. First we solve model MaxBlood to determine the maximum amount of blood that can 
be obtained from the given instance (B*). If the decision maker has an a priori 
knowledge of the blood amount to be collected, this stage can be omitted. 
2. Next, we plug in the optimal value of MaxBlood (B*) into the following mathematical 
model (NodeSelection). We solve this mathematical model on the extended network, 
where the original nodes and the copy ones are treated as individual nodes. The 
parameters of this model are as defined Chapter 5. 
Decision variable: 
7 = 91,  	.)	 ∈ 
′	0	1+*ℎ	*	0*	;	,	--),0,														. 1.																																																																		 & 
NodeSelection: 
minimize?7N

																																																																																																																					D3 
06)*	* 
?7
∈
≥	B∗ (25) 
?7 ≤ 				
∈′
 (26) 
7 ∈ O0,1Q								∀ ∈ 
′						 (27) 
 
This mathematical model is developed in order to find out the nodes that the 
bloodmobiles will visit in order to collect the desired amount of blood. Constraint (25) 
ensures that the visited nodes have enough blood potential to satisfy the blood need. 
Constraint (26) enables the chosen nodes to fit in the planning horizon. Binary 
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restrictions on decision variable are given in constraint set (27). Finally, the objective 
function chooses the nodes that are closer to the depot among the eligible candidates. 
We develop the objective function in this way because the shuttle tours are performed 
every day, and so close nodes to the depot may yield shorter shuttle tours. 
3. Then we feed only the nodes that are obtained in step 2 and their copies for the stay 
overs into MinCost-B*-Blood. With this approach, the model has to handle a 
significantly smaller network. For instance for m collectors and a d-day planning period, 
the model in step 2 (NodeSelection) can result in at most m x d nodes. Considering the 
original nodes and their copies, the upper bound on the network size of MinCost-B*-
Blood is 3m x d with this new approach, whatever the original network is.  
NodeSelection consists of two constraints other that binary restrictions and |N'| = n' 
decision variables. We can conclude that this IP is easier than MinCost-B*-Blood, since 
NodeSelection has a very similar structure to the knapsack problem whereas MinCost-
B*-Blood has a complicated routing problem structure. Also, in step 3 we solve MinCost-
B*-Blood on a considerably smaller network. Therefore, this IP-based heuristic approach 
seems more advantageous than solving MinCost-B*-Blood on the extended network.  
Ankara and Istanbul's original instances and the random instances are used to test the 
performance of the two stage IP-based heuristic algorithm. Since, the Istanbul instances 
are larger, heuristic procedure is also applied to the Istanbul instances with different 
depot locations. Results of heuristic applications for Ankara and Istanbul can be seen in 
Tables 7.1 and 7.2, respectively. 
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Table 7-1 Heuristic Algorithm results for Ankara instances 
exact heuristic 
 objective cpu  objective Stg 1 Stg 2 gap 
actual ctr 912.5 212 sec 912.5 < 1 sec 10 sec 0% 
random ctr 930.9 245 sec 930.9 < 1 sec 11 sec 0% 
maxmin ctr 1037.6 237 sec 1037.6 < 1 sec 64 sec 0% 
weighted ctr 907.1 151 sec 907.1 < 1 sec 67 sec 0% 
 
Table 7-2 Heuristic Algorithm results for Istanbul instances 
exact heuristic 
 objective cpu  objective Stg 1 Stg 2 gap 
actual ctr 446613 2083 sec 446613 < 1 sec 9 sec 0% 
random ctr 899509 5632 sec 899509 < 1 sec 113 sec 0% 
maxmin ctr 577611 3606 sec 577611 < 1 sec 31 sec 0% 
weighted ctr 391779 3234 sec 391779 < 1 sec 6 sec 0% 
In these tables, Stg 1 and Stg 2 corresponds the CPU times of NodeSelection and 
MinCost-B*-Blood model with selected nodes chosen by NodeSelection as input, 
respectively. It can be seen from these tables that, this 2-Stage Algorithm reduces the 
computational times significantly without losing the optimality. All of the instances are 
solved optimally, using this approach. It is an expected result because the optimal 
solution of MaxBlood is give as B* to the node selection algorithm and the subset of 
potential points that yields the maximum amount of blood that can be collected may be 
very few and even sometimes unique. Therefore, the NodeSelection chooses those nodes 
and when we feed those nodes to MinCost-B*-Blood we obtain the same results very 
quickly this time. Yet, since this is an IP-based heuristic, its computational performance 
might be worse for much larger instances. However, we always know that the maximum 
size of the input matrix of Stage 2 will be at most mdt, where m, d and t corresponds to 
the number of bloodmobiles, the length of the planning horizon and maximum allowed 
length of a stayover, respectively.  
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Chapter 8  
 
Conclusion & Future Research 
Directions 
Mobile blood collection systems yield dramatic improvements on countries' blood 
collection processes if applied efficiently. Turkey needs an effective, well-planned blood 
supply chain, since it suffered many earthquakes in the past and will be in the future. In 
this research, we focused on the problem of designing a new bloodmobile system for 
TRC, which is cost efficient and easy-to-implement.  
In the current mobile blood collection system of TRC, bloodmobiles perform 
independent direct tours between the depot and certain activities such as fairs, fests and 
company blood donation campaigns. Other than that, they usually serve as a fixed point. 
Even for the activities that last longer than one day, they travel to the donation point at 
the beginning of the day and return to the depot in the evening to prevent the blood 
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perishing. There are two main problems about this approach. Firstly, the bloodmobiles 
perform redundant tours for the activities that lasts longer than one day or for the 
donation points which are very close to each other. As a result, a second problem occurs: 
the bloodmobiles only visit the points which have a very high expected blood potential 
in order to keep logistics costs low.  
As it is explained in Chapter 4, the proposed system consists of original bloodmobiles in 
addition to a shuttle. With the implementation of this new system, bloodmobiles do not 
need to come back to the depot to bring the blood, but instead, the shuttle visits the 
bloodmobiles on-the-roads and transports the collected blood to the analysis center. The 
healthcare, blood logistics and selective vehicle routing literature is explored. However 
no study that covers all the aspects of the described problem is encountered. As a result, 
the selective vehicle routing approach is extended to consider the shuttle tours as well 
and a new problem named as the Selective VRP with Integrated Tours is introduced to 
the literature.  
A mathematical model, Mincost-B*-Blood, is described in Chapter 5 with size of 
variables O(n2d), where n and d corresponds to number of nodes in the network and the 
length of the planning horizon respectively. This model, minimizes the logistics cost that 
is paid to collect a pre-defined blood level of B* and decides on the stops and stop-
lengths of bloodmobiles and the tours of shuttles and bloodmobiles. B* can be 
determined by decision makers according to the inventory level of blood, or they can 
choose to collect the maximum amount of blood possible with respect to the number of 
vehicle and planning horizon length. To obtain the maximum amount of blood for a 
given network and parameters, another mixed integer program, MaxBlood, was built. 
Also, three different valid inequalities are defined to improve the computational 
performance of Mincost-B*-Blood in Chapter 5. 
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In Chapter 6, the data sets that are used to test the performance of developed models are 
explained. Ankara instance is constructed based on the past blood collection data of 
TRC, whereas Istanbul instance is created using the centers and populations of the 
European part of the city. First, MaxBlood is solved for these two instances, then the 
results are fed to Mincost-B*-Blood. The optimal solutions showed that the proposed 
system results in better logistics costs than the current one in both cities. Also, an 
analysis on depot location is performed, alternative depot locations are suggested and the 
total logistics costs are compared with the original depot locations. We observed that the 
best logistics costs is be achieved if the depot is located to the point which minimizes the 
weighted distances to other nodes. Performances of the valid inequalities defined in 
Chapter 5 are tested as well. However, the performances of these inequalities are not 
consistent. In addition, we constructed the Pareto Efficient curves of both instances to 
see the interaction between the two major objectives under consideration: maximization 
of the collected blood and minimization of the total logistics costs. We observed that if 
TRC settles for the 90% of the maximum amount of blood, they can increase the logistic 
expenses dramatically. Finally, sensitivity analysis conducted on the number of vehicles 
and the value of the blood potential estimation parameter β. We concluded that 
increasing the number of bloodmobiles is not effective for most of the cases. We can 
also suggest that maintaining high β values yields very high blood collection amounts. In 
order to do so, TRC may need to make early announcements of the date and duration of 
blood collection activities.  
The performance of Mincost-B*-Blood is satisfactory for the data sets in hand. However, 
for larger instances, it is not very promising in terms of computational requirements. 
Therefore, a 2-stage heuristic algorithm is developed to handle this issue. The main 
motivation behind the algorithm is to put an upper bound on the network size which is 
fed to the Mincost-B*-Blood model. Thus, we develop another integer program 
NodeSelection, which determines the nodes that have blood potential greater than or 
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equal to B* and that can be visited in the planning horizon by the bloodmobiles. The 
NodeSelection chooses the points according to their distances to the depot then, only the 
points that are selected by NodeSelection are fed to MinCost-B*-Blood. This approach 
guarantees that, the input network of MinCost-B*-Blood could have at most mdt nodes, 
when the number of bloodmobiles are m, the length of planning horizon is d and the 
maximum stay-over-length is t. The approach resulted with significant decreases of 
computational times. All instances are solved optimally and computational times 
reduced significantly with the use of this approach. 
Within the scope of this study, we proposed an efficient way for increasing blood 
donations in Turkey. To this end, we focused on the mobile blood collection vehicles 
and designed a new bloodmobile system. We showed that attaining high collection 
levels is possible with relatively low logistics costs. Also, we introduced a new problem 
to the literature and tested it on several instances to obtain managerial insights for the 
decision making process of TRC. Finally, for larger instances we designed an IP-based 
heuristic algorithm.  
As a future direction, one can investigate possible alternative application areas for 
SVRPwIT. For instance, carrying medical supplements such as serum, antibiotics to 
mobile healthcare facilities which are described in Hodgson et al. is a possible 
application since those kind of supplements need to be carried and stored in cold-chains 
and the technology available in mobile healthcare facilities may not be sufficient to keep 
those items fresh for days or they may need replenishment. Similarly, a shuttle can 
collect the blood or urine samples from the mobile healthcare vehicles for testing.  
Besides the practical future applications, one can also develop a meta-heuristic for 
SVRPwIT tours even though generating a feasible solution or defining neighborhoods is 
much more complicated than the classical SVRP problems. Also, it is possible to define 
valid inequalities other than that are developed in this study. Finally, since SVRPwIT is 
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a new problem performing the polyhedral analysis of this concept may also be a fruitful 
avenue of further research. 
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Appendix 1  Potential Stops, Blood Potentials and the Distance Matrix of Ankara Instance 
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Appendix 2 Selected Nodes, Bloodmobile and Shuttle Tours Found for Ankara Instance 
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Appendix 3 Selected Nodes, Bloodmobile and Shuttle Tours Found for Istanbul Instance
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Appendix 4 Location of Depot in Random Instances 
Instance 16:
 
Instance 17:
 
 
 92 
 
Instance 18:
 
Instance 19:
 
 
 
 93 
 
Instance 20:
 
Instance 21:
 
 
 
 94 
 
Instance 22:
 
Instance 23:
 
 
 
 95 
 
Instance 24:
 
Instance 25:
 
 
 
 96 
 
Instance 26:
 
Instance 27 :
 
 
 
 97 
 
Instance 28:
 
Instance 29 :
 
 
 
 98 
 
Instance 30:
 
 
